Charles Peyton

NPI: 1205195195
Total Payments
$16,163
2024 Payments
$10,980
Companies
14
Transactions
49
Medicare Patients
1,174
Medicare Billing
$105,711

Payment Breakdown by Category

Other$8,000 (49.5%)
Education$4,035 (25.0%)
Food & Beverage$2,755 (17.0%)
Travel$1,373 (8.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Education $4,035 4 25.0%
Honoraria $4,000 1 24.7%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,000 1 24.7%
Food and Beverage $2,755 40 17.0%
Travel and Lodging $1,373 3 8.5%

Top Paying Companies

Company Total Records Latest Year
UROGEN PHARMA, INC. $6,181 10 $0 (2024)
Boston Scientific Corporation $4,315 4 $0 (2024)
INTUITIVE SURGICAL, INC. $3,692 4 $0 (2024)
COLOPLAST CORP $641.20 12 $0 (2024)
AngioDynamics, Inc. $434.35 4 $0 (2022)
Janssen Research & Development, LLC $280.00 5 $0 (2023)
Ferring Pharmaceuticals Inc. $157.49 2 $0 (2024)
Photocure Inc $89.05 2 $0 (2022)
KARL STORZ Endoscopy-America $87.16 1 $0 (2023)
Janssen Scientific Affairs, LLC $78.98 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $10,980 15 UROGEN PHARMA, INC. ($5,995)
2023 $517.22 8 Janssen Research & Development, LLC ($180.00)
2022 $1,104 16 Coloplast Corp ($422.62)
2021 $190.64 3 AngioDynamics, Inc. ($112.47)
2020 $3,192 3 Intuitive Surgical, Inc. ($3,192)
2019 $77.90 1 AstraZeneca Pharmaceuticals LP ($77.90)
2018 $14.00 1 PFIZER INC. ($14.00)
2017 $86.61 2 BOSTON SCIENTIFIC CORPORATION ($46.52)

All Payment Transactions

49 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/13/2024 Ferring Pharmaceuticals Inc. ADSTILADRIN (Biological) Food and Beverage In-kind items and services $98.26 General
Category: ONCOLOGY
12/05/2024 Ferring Pharmaceuticals Inc. ADSTILADRIN (Biological) Food and Beverage In-kind items and services $59.23 General
Category: ONCOLOGY
11/06/2024 INTUITIVE SURGICAL, INC. Da Vinci Surgical System (Device) Education Cash or cash equivalent $500.00 General
Category: SURGERY
10/04/2024 Boston Scientific Corporation AMS 700 (Device) Food and Beverage In-kind items and services $152.90 General
Category: AMS 700_URO
09/25/2024 Boston Scientific Corporation LithoVue (Device) Food and Beverage In-kind items and services $115.43 General
Category: LithoVue_URO
09/06/2024 UROGEN PHARMA, INC. Travel and Lodging Cash or cash equivalent $696.46 General
09/06/2024 UROGEN PHARMA, INC. Education Cash or cash equivalent $525.00 General
09/06/2024 UROGEN PHARMA, INC. Travel and Lodging Cash or cash equivalent $496.95 General
07/17/2024 UROGEN PHARMA, INC. JELMYTO (Drug) Education In-kind items and services $10.00 General
Category: UROTHELIAL CANCER
06/26/2024 COLOPLAST CORP Titan (Device) Food and Beverage In-kind items and services $59.37 General
Category: Men's Health
05/03/2024 UROGEN PHARMA, INC. JELMYTO (Drug) Honoraria Cash or cash equivalent $4,000.00 General
Category: UROTHELIAL CANCER
05/03/2024 UROGEN PHARMA, INC. JELMYTO (Drug) Food and Beverage In-kind items and services $125.00 General
Category: UROTHELIAL CANCER
05/03/2024 UROGEN PHARMA, INC. JELMYTO (Drug) Food and Beverage In-kind items and services $21.71 General
Category: UROTHELIAL CANCER
03/22/2024 Boston Scientific Corporation Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,000.00 General
Category: General - IO Ablation_PI
03/21/2024 UROGEN PHARMA, INC. JELMYTO (Drug) Food and Beverage In-kind items and services $119.83 General
Category: UROTHELIAL CANCER
11/29/2023 Janssen Research & Development, LLC Food and Beverage In-kind items and services $60.00 General
11/29/2023 Janssen Research & Development, LLC Food and Beverage In-kind items and services $60.00 General
11/29/2023 Janssen Research & Development, LLC Food and Beverage In-kind items and services $60.00 General
06/22/2023 Coloplast Corp Titan (Device) Food and Beverage In-kind items and services $48.02 General
Category: Men's Health
06/22/2023 Coloplast Corp Porges Coloplast (Device) Food and Beverage In-kind items and services $48.02 General
Category: Endourology
06/20/2023 Janssen Scientific Affairs, LLC ERLEADA (Drug) Food and Beverage In-kind items and services $78.98 General
Category: Oncology
03/15/2023 PALETTE LIFE SCIENCES, INC. Food and Beverage In-kind items and services $75.04 General
02/08/2023 KARL STORZ Endoscopy-America Flex-X / IMAGE 1 S (Device) Food and Beverage In-kind items and services $87.16 General
Category: UROLOGY
12/14/2022 Coloplast Corp Titan (Device) Food and Beverage In-kind items and services $10.69 General
Category: Men's Health
12/02/2022 UroGen Pharma, Inc. JELMYTO (Drug) Food and Beverage In-kind items and services $110.33 General
Category: UROTHELIAL CANCER

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 340 479 $199,275 $31,315
2022 12 345 477 $188,566 $31,253
2021 12 281 366 $177,870 $27,190
2020 11 208 237 $85,245 $15,953
Total Patients
1,174
Total Services
1,559
Medicare Billing
$105,711
Procedure Codes
49

All Medicare Procedures & Services

49 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 32 51 $17,799 $5,125 28.8%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 50 50 $20,550 $4,609 22.4%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 34 34 $17,306 $4,415 25.5%
52000 Diagnostic exam of bladder and urethra using an endoscope Facility 2023 50 77 $66,913 $4,072 6.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 39 44 $10,824 $3,053 28.2%
52235 Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm Facility 2023 13 14 $17,262 $2,859 16.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 31 35 $8,610 $2,406 27.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 11 11 $3,839 $1,178 30.7%
51702 Simple insertion of temporary bladder tube Facility 2023 19 51 $15,861 $821.92 5.2%
99443 Telephone medical discussion with physician, 21-30 minutes Facility 2023 12 12 $2,580 $797.72 30.9%
51701 Insertion of temporary bladder tube Facility 2023 14 49 $11,760 $792.54 6.7%
74420 Imaging of urinary tract following injection of a contrast agent Facility 2023 20 35 $3,395 $644.00 19.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 15 16 $2,576 $542.85 21.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 39 52 $18,148 $5,456 30.1%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 39 39 $19,851 $5,354 27.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 61 69 $16,974 $4,858 28.6%
52000 Diagnostic exam of bladder and urethra using an endoscope Facility 2022 53 74 $64,306 $4,146 6.4%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 41 41 $16,851 $3,972 23.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 20 26 $6,396 $1,796 28.1%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 14 23 $4,830 $1,218 25.2%
51701 Insertion of temporary bladder tube Facility 2022 12 56 $13,440 $1,081 8.0%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 11 11 $3,707 $1,049 28.3%
51720 Instillation of anti-cancer drug into bladder Facility 2022 13 23 $10,764 $682.16 6.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 12 12 $1,932 $625.69 32.4%
51702 Simple insertion of temporary bladder tube Facility 2022 18 30 $9,330 $605.98 6.5%

About Charles Peyton

Charles Peyton is a Urology healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2012. The National Provider Identifier (NPI) number assigned to this provider is 1205195195.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Charles Peyton has received a total of $16,163 in payments from pharmaceutical and medical device companies, with $10,980 received in 2024. These payments were reported across 49 transactions from 14 companies. The most common payment nature is "Education" ($4,035).

As a Medicare-enrolled provider, Peyton has provided services to 1,174 Medicare beneficiaries, totaling 1,559 services with total Medicare billing of $105,711. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.

Practice Information

  • Specialty Urology
  • Location Birmingham, AL
  • Active Since 05/11/2012
  • Last Updated 06/29/2023
  • Taxonomy Code 208800000X
  • Entity Type Individual
  • NPI Number 1205195195

Products in Payments

  • JELMYTO (Drug) $4,462
  • Da Vinci Surgical System (Device) $3,692
  • Titan (Device) $593.18
  • NANOKNIFE (Device) $321.88
  • ADSTILADRIN (Biological) $157.49
  • AMS 700 (Device) $152.90
  • LithoVue (Device) $115.43
  • NanoKnife (Device) $112.47
  • Flex-X / IMAGE 1 S (Device) $87.16
  • ERLEADA (Drug) $78.98
  • CYSVIEW (Drug) $74.05
  • Porges Coloplast (Device) $48.02
  • AMS (Device) $46.52
  • Cysview (Drug) $15.00
  • SUTENT (Drug) $14.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Urology Doctors in Birmingham